Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy
Status:
Withdrawn
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies ciprofloxacin compared to an inactive treatment (placebo) in
diagnosing prostate cancer in patients undergoing removal of prostate cells or tissues for
examination (biopsy). Ciprofloxacin is an antibiotic, a type of drug used to treat infections
caused by bacteria. Giving ciprofloxacin to patients undergoing a prostate biopsy may help to
lower abnormal prostate-specific antigen (PSA) levels caused by bacterial infection of the
prostate gland and may or may not affect the detection rate of prostate cancer.